8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jul 24, 2007)

Filed July 24, 2007For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on July 24, 2007, to report its financial results for the quarter and six months ended June 30, 2007. This filing primarily serves to incorporate by reference a press release containing this financial information. Investors seeking details on the company's performance, including key metrics like revenue, earnings per share, and any forward-looking guidance, should refer to the press release (Exhibit 99.1) attached to this 8-K. While the 8-K itself does not contain the detailed financial figures, it signifies the official dissemination of the second quarter 2007 performance data. Investors are encouraged to review the referenced press release for a comprehensive understanding of Quest Diagnostics' operational and financial condition as of and for the periods ending June 30, 2007.

Key Highlights

  • 1Quest Diagnostics filed an 8-K on July 24, 2007, reporting its financial results.
  • 2The filing pertains to the financial results for the quarter and six months ended June 30, 2007.
  • 3The core of the filing is the incorporation by reference of a press release (Exhibit 99.1).
  • 4This press release contains the detailed financial information regarding the company's performance.
  • 5The filing officially disseminates the Q2 2007 financial results to the public and investors.
  • 6Robert A. Hagemann, Senior Vice President and Chief Financial Officer, signed the filing.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Quest Diagnostics Incorporated's financial results for the quarter and six months ended June 30, 2007, by incorporating a press release containing this information.

The detailed financial results are located in the press release dated July 24, 2007, which is attached as Exhibit 99.1 to this 8-K filing and is incorporated by reference.

This 8-K filing does not provide the specific financial metrics. To find details on revenue, earnings per share, or other performance indicators for the quarter and six months ended June 30, 2007, investors must refer to the press release (Exhibit 99.1) attached to this filing.

The filing was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated, indicating his responsibility for the reported financial information.